Bicocca Open Archive

Logo unimib boa
SALA, GESSICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.858
EU - Europa 3.709
AS - Asia 1.306
SA - Sud America 37
Continente sconosciuto - Info sul continente non disponibili 10
AF - Africa 4
OC - Oceania 1
Totale 11.925
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.742
IT - Italia 850
DE - Germania 685
CN - Cina 540
SE - Svezia 526
IE - Irlanda 396
SG - Singapore 357
UA - Ucraina 298
RU - Federazione Russa 254
GB - Regno Unito 219
HK - Hong Kong 130
AT - Austria 112
CA - Canada 111
FI - Finlandia 100
IN - India 84
FR - Francia 58
PL - Polonia 52
VN - Vietnam 52
DK - Danimarca 47
IR - Iran 39
BE - Belgio 38
BR - Brasile 33
NL - Olanda 32
TR - Turchia 31
JP - Giappone 20
KR - Corea 18
ID - Indonesia 17
CZ - Repubblica Ceca 9
EU - Europa 9
ES - Italia 8
GR - Grecia 5
RO - Romania 5
CH - Svizzera 4
MX - Messico 4
PT - Portogallo 4
TW - Taiwan 4
PK - Pakistan 3
CL - Cile 2
CY - Cipro 2
MU - Mauritius 2
MY - Malesia 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
A1 - Anonimo 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BO - Bolivia 1
BZ - Belize 1
CO - Colombia 1
EE - Estonia 1
EG - Egitto 1
GA - Gabon 1
HU - Ungheria 1
IL - Israele 1
KH - Cambogia 1
KZ - Kazakistan 1
LK - Sri Lanka 1
NO - Norvegia 1
PH - Filippine 1
Totale 11.925
Salva come PNG Salva come JPEG
Città #
Ann Arbor 1.609
Woodbridge 679
Chandler 545
Houston 482
Frankfurt am Main 475
Fairfield 392
Dublin 380
Ashburn 372
Jacksonville 343
Wilmington 319
Singapore 288
Milan 278
Dearborn 263
New York 210
Seattle 165
Princeton 152
Cambridge 135
Hong Kong 128
Vienna 112
Shanghai 99
Nanjing 90
Santa Clara 80
Boardman 68
Lachine 61
Altamura 53
Lawrence 47
Kraków 44
Beijing 39
Brussels 37
Fremont 36
Helsinki 31
Shenyang 31
Pisa 30
Guangzhou 29
Nanchang 27
Dong Ket 26
San Diego 26
Changsha 25
Andover 24
Rome 24
Jinan 23
Falls Church 22
Hebei 22
Tianjin 22
Grafing 21
Pune 21
Jiaxing 19
Lecco 19
Monza 19
Turin 19
London 18
Zhengzhou 18
Dallas 17
Jakarta 17
Munich 17
Ottawa 17
Toronto 17
Tehran 16
Ningbo 13
Mountain View 12
Norwalk 11
Auburn Hills 10
Lissone 10
Cinisello Balsamo 9
Detroit 9
Edmonton 9
Hangzhou 9
Huizen 9
Kunming 9
Los Angeles 9
Bologna 8
Brno 8
Desio 8
Hefei 8
Itaborai 8
Redmond 8
Belo Horizonte 7
Nürnberg 7
Bari 6
Florence 6
Lappeenranta 6
Paderno Dugnano 6
Pioltello 6
Rho 6
San Mateo 6
Zanjan 6
Amsterdam 5
Leawood 5
Monmouth Junction 5
University Park 5
Washington 5
Cambiago 4
Carate Brianza 4
Chicago 4
Daejeon 4
Falkenstein 4
Kiev 4
Lanzhou 4
Melegnano 4
Moscow 4
Totale 8.888
Salva come PNG Salva come JPEG
Nome #
ALS Cognitive Behavioral Screen (ALS-CBS): normative values for the Italian population and clinical usability 418
NMR-driven identification of anti-amyloidogenic compounds in green and roasted coffee extracts 348
Rotenone down-regulates HSPA8/hsc70 chaperone protein in vitro: A new possible toxic mechanism contributing to Parkinson's disease 292
Oxidative stress and altered mitochondrial dynamics in neurodegenerative processes 265
Serum naturally occurring anti-TDP-43 auto-antibodies are increased in amyotrophic lateral sclerosis 253
Riluzole Selective Antioxidant Effects in Cell Models Expressing Amyotrophic Lateral Sclerosis Endophenotypes 236
NMR-based Lavado cocoa chemical characterization and comparison with fermented cocoa varieties: insights on cocoa’s anti-amyloidogenic activity 235
Reduced platelet glutamate uptake in Parkinson's disease 233
Ischemic Conditions Affect Rerouting of Tau Protein Levels: Evidences for Alteration in Tau Processing and Secretion in Hippocampal Neurons 232
HSC70 expression is reduced in lymphomonocytes of sporadic ALS patients and contributes to TDP-43 accumulation 211
Valproate and HDAC inhibition: A new epigenetic strategy to mitigate phenotypic severity in ALS? 200
Rotenone upregulates alpha-synuclein and myocyte enhancer factor 2D independently from lysosomal degradation inhibition 200
Increased susceptibility to plasma lipid peroxidation in Alzheimer disease patients 198
Impairment of glutamate transport and increased vulnerability to oxidative stress in neuroblastoma SH-SY5Y cells expressing a Cu,Zn superoxide dismutase typical of familial amyotrophic lateral sclerosis 195
In vitro study of autophagy dysfunctions associated with Parkinson’s disease 194
Rotenone-induced down-regulation of HSPA8/hsc70 protein increases alphasynuclein in vitro: possible implications for Parkinson’s disease 193
Peripheral cytokine release in Alzheimer patients: Correlation with disease severity 188
Vesicular monoamine transporter 2 mRNA levels are reduced in platelets from patients with Parkinson's disease 180
Study of alpha-synuclein and its catabolic pathways in ex vivo cells of patients with Parkinson’s disease 180
Platelet glutamate uptake as peripheral marker of excitotoxicity in neurodegenerative disorders 177
Leber hereditary optic neuropathy mtDNA mutations disrupt glutamate transport in cybrid cell lines 175
Glutamate transporters in platelets: EAAT1 decrease in aging and in Alzheimer's disease 168
Rotenone down-regulates hspa8/hsc70 protein in vitro: a new possible toxic mechanism contributing to Parkinson’s disease 165
Alpha-Synuclein, Oxidative Stress and Autophagy Failure: Dangerous Liaisons in Dopaminergic Neurodegeneration 164
Reduced expression of the chaperone-mediated autophagy carrier hsc70 protein in lymphomonocytes of patients with Parkinson's disease 163
Study Of Chaperone Mediated Autophagy in Lymphomonocytes of sporadic and familial als patients evidenced Hsc70 reduction and TDP-43 aggregation 163
Huntington's disease and HDACi: Would sulpiride and valproate be of therapeutic value? 162
Lack of evidence for oxidative stress in sporadic amyotrophic lateral sclerosis fibroblasts 161
Pravastatin acute neuroprotective effects depend on blood brain barrier integrity in experimental cerebral ischemia 161
Nerve growth factor and transforming growth factor-β serum levels in acute stroke patients: Possible involvement of neurotrophins in cerebrovascular disease 159
Decreased platelet glutamate uptake and genetic risk factors in patients with Parkinson's disease 159
Acute lipophilicity-dependent effect of intravascular simvastatin in the early phase of focal cerebral ischemia 159
Effect of mitochondrial complex I inhibition on chaperone-mediated and myocyte enhancer factor 2D in human neuroblastoma cells 159
A panel of macroautophagy markers in lymphomonocytes of patients with amyotrophic lateral sclerosis 158
AUTOPHAGY ALTERATION UNDER ISCHEMIC CONDITION: A POSSIBLE LINK TO ALZHEIMER'S DISEASE 158
Myocyte Enhacer Factor 2 Pathway Disruption in Lymphomonocytes of Patients with Sporadic and Familial Form of Amyotrophic Lateral Sclerosis 157
Riluzole display glutamate-independent antioxidant properties: relevance for ALS 153
MEF2D and MEF2C pathways disruption in sporadic and familial ALS patients 148
Inhibition of retrograde transport modulates misfolded protein accumulation and clearance in motoneuron diseases 148
Mitochondrial dysfunction due to mutant copper/zinc superoxide dismutase associated with amyotrophic lateral sclerosis is reversed by N-acetylcysteine 144
Reduced expression of hsc70 protein in lymphomonocytes of patients with Parkinson's disease 143
Exploring the role of autophagy in the pathogenesis of rotenone-induced toxicity 141
Ischemic injury elicits the unconventional secretion of protein hallmarks of Alzheimer's disease onset as seeds for interneuronal propagation 141
Common variants in Alzheimer's disease and risk stratification by polygenic risk scores 139
Partial mitochondrial complex I inhibition induces oxidative damage and perturbs glutamate transport in primary retinal cultures. Relevance to Leber Hereditary Optic Neuropathy (LHON) 138
Assessment of chaperone-mediated autophagy in circulating lymphomonocytes of patients with Parkinson disease 138
A Preliminary Study of Chaperone-Mediated Autophagy in ALS Lymphomonocytes 135
Analysis of glutamate transporters in peripheral cells: A tool to invistigate excitotoxicity in neurodegenerative disorders 134
MEF2D and MEF2C Pathways Disruption in Sporadic and Familial ALS Patients 131
NMR-driven identification of cinnamon bud and bark components with anti-Aβ activity 130
Decreased platelet glutamate uptake in patients with amyotrophic lateral sclerosis 129
Myocyte enhancer factor-2D expression in ALS lymphomonocytes 127
Study of alpha-synuclein and its catabolic pathways in lymphomonocytes of patients with Parkinson's disease 125
the MonzALS collaborative network 124
MEF2C and MEF2D alterations in sporadic and familial ALS patients: a possible correlation with disease progression? 124
Macroautophagy is not altered in ALS lymphomonocytes 122
Role of chaperone-mediated autophagy dysfunctions in the pathogenesis of Parkinson’s disease 122
Chaperone mediated autophagy in Parkinson's disease: Study in peripheral blood cells from patients and in a cellular model 120
Mef2d-mef2c pathways are altered in lymphomonocytes of patients with sporadic and familial form of amyotrophic lateral sclerosis 118
Increased interleukin-6 release from peripheral blood cells of patients after brain trauma 118
Direct current stimulation enhances neuronal alpha-synuclein degradation in vitro 116
New insights into the genetic etiology of Alzheimer's disease and related dementias 113
HSPA8 knock-down induces the accumulation of neurodegenerative disorder-associated proteins 111
Whole-blood global DNA methylation and phenotypic variability in ALS 110
Alzheimer's Disease Prevention through Natural Compounds: Cell-Free, in Vitro, and in Vivo Dissection of Hop (Humulus lupulus L.) Multitarget Activity 109
Assessing glutamatergic function and dysfunction in peripheral tissues 109
Antioxidants partially restore glutamate transport defect in leber hereditary optic neuropathy cybrids 108
Myocyte Enhacer Factor 2 Pathway Disruption in Lymphomonocytes of Patients with Sporadic and Familial Form of Amyotrophic Lateral Sclerosis 108
Interactions between excitotoxicity and oxidative stress in ALS: clues for pharmacotherapy 106
Dysfunction of chaperone-mediated autophagy in lymphomonocytes from patients with Parkinson's disease and in a cellular model 106
Valproate Treatment in an ALS Patient Carrying a c.194G>A Spastin Mutation and SMN2 Homozygous Deletion 103
Myocyte Enhacer Factor-2 Pathway Is Altered In Amyotrophic Lateral Sclerosis Peripheral Blood Mononuclear Cells 102
Whole-blood global DNA methylation is increased in amyotrophic lateral sclerosis independently of age of onset 96
Recent advances in the therapy of amyotrophic lateral sclerosis: Focus on excitotoxicity 94
Digested Cinnamon (Cinnamomum verum J. Presl) Bark Extract Modulates Claudin-2 Gene Expression and Protein Levels under TNFα/IL-1β Inflammatory Stimulus 90
ALS genocopy due to co-existence of spastin mutation and SMN2 deletion? A 12 months open label trial with valproic acid 87
TSPO Modulates Oligomeric Amyloid-β-Induced Monocyte Chemotaxis: Relevance for Neuroinflammation in Alzheimer's Disease 83
Platelets 75
Author Correction: Direct current stimulation enhances neuronal alpha-synuclein degradation in vitro (Scientific Reports, (2021), 11, 1, (2197), 10.1038/s41598-021-81693-8) 37
Author Correction: Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores (Nature Communications, (2021), 12, 1, (3417), 10.1038/s41467-021-22491-8) 26
Glibenclamide-Loaded Engineered Nanovectors (GNVs) Modulate Autophagy and NLRP3-Inflammasome Activation 26
Neuroprotection and Non-Invasive Brain Stimulation: Facts or Fiction? 22
Totale 12.348
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.914
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.914
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.499 0 0 136 126 161 240 297 122 155 109 119 34
2020/20211.498 86 86 145 182 107 81 134 131 132 173 98 143
2021/20221.120 97 126 109 100 81 113 45 57 50 69 108 165
2022/20232.119 190 615 193 239 163 321 26 117 144 17 50 44
2023/20241.674 81 79 104 88 201 456 239 90 79 14 31 212
2024/2025735 170 407 158 0 0 0 0 0 0 0 0 0
Totale 12.348